<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01039766</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-09-7128-AJW-CTIL</org_study_id>
    <nct_id>NCT01039766</nct_id>
  </id_info>
  <brief_title>The Efficacy of a Single Dose of Intranasal Oxytocin in the Prevention of Post Traumatic Stress Disorder (PTSD)</brief_title>
  <official_title>The Efficacy of the Proximate Administration of Oxytocin After a Traumatic Event in Preventing the Development of Post Traumatic Stress Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to test the hypothesis that a single administration of intranasal
      oxytocin within 6 hours post-trauma facilitates the physiological recovery for the trauma,
      thereby preventing the development of Post Traumatic Stress Disorder (PTSD) in the months
      following the event. In the absence of such treatment (i.e., under placebo conditions), we
      hypothesize that a greater proportion of persons will develop PTSD (i.e., fail to recover
      from acute effects).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a double-blind, placebo-controlled trial in which trauma victims are randomized to
      receive a single intranasal administration of either Oxytocin (40IU) or placebo within the
      first six hours following trauma exposure. To provide a pre-treatment baseline, participants
      will receive a medical and psychological evaluation prior to treatment. After two weeks the
      research assistant or study psychiatrist will perform behavioral ratings and complete history
      details pertaining to PTSD risk factors. Participants will be assessed again by the study
      psychiatrist or research assistants at 1, 3, 6 and 13 months. Eligible subjects will include
      men and women over the age of 18, who have been exposed to an event meeting the DSM-IV &quot;A.1&quot;
      criterion for trauma exposure, and who provide written, informed consent to participate in
      the study. In order to recruit persons who are more likely to be at risk for the development
      of PTSD, we will only randomize persons expressing marked anxiety, emotional distress or
      dissociation, as assessed by the Visual Analog Scales. Potential participants will be
      recruited from trauma victims arriving at the Chaim Sheba Medical Center Emergency Room.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Anticipated">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome measure is DSM-IV diagnosis of PTSD at the end of the trial.</measure>
    <time_frame>13 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary outcome measure is the severity of PTSD as expressed by the Clinician Administered PTSD Scale (CAPS), at the end of the trial.</measure>
    <time_frame>13 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Stress Disorders, Post-Traumatic</condition>
  <arm_group>
    <arm_group_label>oxytocin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <description>A single intranasal administration of 40 IU of oxytocin will be given to patients up to 6 hours after a traumatic event, with consecutive follow up for 13 months.</description>
    <arm_group_label>oxytocin</arm_group_label>
    <other_name>syntocinon nasal spray</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo - saline nasal spray</intervention_name>
    <description>A single intranasal administration of saline will be given to patients up to 6 hours after a traumatic event, with consecutive follow up for 13 months as the control to the oxytocin arm</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>saline nasal spray prepared by the hospital's pharmacy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Persons over the age of 18, who have been exposed to an event meeting the DSM-IV &quot;A.1&quot;
             criterion for trauma exposure, expressing marked anxiety, and/ or emotional distress
             and/or dissociation, as assessed by the Visual Analog Scales

          2. The traumatic event occured up to six hour prior to the arrival to the emergency room

          3. The person can and is willing to provide written, informed consent to participate in
             the study.

        Exclusion Criteria:

          1. Physical injury that would contraindicate participation or interfere with a subject's
             ability to give informed consent or cooperate with the screening or collection of
             initial measures. Examples include severe burn injury, life-threatening medical or
             surgical condition, condition requiring surgical intervention under general
             anesthesia, as indicated by Abbreviated Injury Scale (AIS), or by clinical judgment;

          2. Head injury involving confusion, loss of consciousness, or amnesia;

          3. Medical conditions in which oxytocin administration might cause harm to the patient
             such as patients with a cardiovascular disease or intracranial mass.

          4. Weight below 45 or above 100 kg.

          5. Pregnancy (in suggestive cases, a pregnancy test will be performed);

          6. Traumatic exposure that reflects ongoing victimization (e.g., domestic violence) to
             which the subject is likely to be re-exposed during the study period.

          7. Overt psychopathology, intoxication, or under the influence of substances.

          8. Evidence or history of schizophrenia, bipolar, other psychotic condition, autism;

          9. Prior history of PTSD;

         10. Current or past history of dementia, amnesia, or other cognitive disorder predating
             trauma exposure;

         11. Assessed serious suicide risk.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>67 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alzbeta Juven Wetzler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joseph Zohar, MD</last_name>
    <phone>972-3-5303300</phone>
    <email>jzohar@post.tau.ac.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shlomit Cwikel-Hamzany, MD</last_name>
    <phone>972-52-4746120</phone>
    <email>shlomitch@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Zohar, MD</last_name>
      <phone>972-3-5303300</phone>
      <email>jzohar@post.tau.ac.il</email>
    </contact>
    <contact_backup>
      <last_name>Shlomit Cwikel-Hamzany, MD</last_name>
      <phone>972-52-4746120</phone>
      <email>shlomitch@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Andrews B, Brewin CR, Rose S, Kirk M. Predicting PTSD symptoms in victims of violent crime: the role of shame, anger, and childhood abuse. J Abnorm Psychol. 2000 Feb;109(1):69-73.</citation>
    <PMID>10740937</PMID>
  </reference>
  <reference>
    <citation>Beckner VE, Tucker DM, Delville Y, Mohr DC. Stress facilitates consolidation of verbal memory for a film but does not affect retrieval. Behav Neurosci. 2006 Jun;120(3):518-27.</citation>
    <PMID>16768603</PMID>
  </reference>
  <reference>
    <citation>Davidson JR, Tupler LA, Wilson WH, Connor KM. A family study of chronic post-traumatic stress disorder following rape trauma. J Psychiatr Res. 1998 Sep-Oct;32(5):301-9.</citation>
    <PMID>9789209</PMID>
  </reference>
  <reference>
    <citation>Koenen KC, Harley R, Lyons MJ, Wolfe J, Simpson JC, Goldberg J, Eisen SA, Tsuang M. A twin registry study of familial and individual risk factors for trauma exposure and posttraumatic stress disorder. J Nerv Ment Dis. 2002 Apr;190(4):209-18.</citation>
    <PMID>11960081</PMID>
  </reference>
  <reference>
    <citation>Kuhlmann S, Wolf OT. Arousal and cortisol interact in modulating memory consolidation in healthy young men. Behav Neurosci. 2006 Feb;120(1):217-23.</citation>
    <PMID>16492134</PMID>
  </reference>
  <reference>
    <citation>Lupien SJ, Maheu F, Tu M, Fiocco A, Schramek TE. The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition. Brain Cogn. 2007 Dec;65(3):209-37. Epub 2007 Apr 26. Review.</citation>
    <PMID>17466428</PMID>
  </reference>
  <reference>
    <citation>Stein MB, Jang KL, Taylor S, Vernon PA, Livesley WJ. Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study. Am J Psychiatry. 2002 Oct;159(10):1675-81.</citation>
    <PMID>12359672</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, Bierer LM, Schmeidler J, Aferiat DH, Breslau I, Dolan S. Low cortisol and risk for PTSD in adult offspring of holocaust survivors. Am J Psychiatry. 2000 Aug;157(8):1252-9.</citation>
    <PMID>10910787</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, Halligan SL, Bierer LM. Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring. J Psychiatr Res. 2001 Sep-Oct;35(5):261-70.</citation>
    <PMID>11591428</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, Halligan SL, Grossman R. Childhood trauma and risk for PTSD: relationship to intergenerational effects of trauma, parental PTSD, and cortisol excretion. Dev Psychopathol. 2001 Summer;13(3):733-53.</citation>
    <PMID>11523857</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, Harvey PD, Buchsbaum M, Tischler L, Schmeidler J. Enhanced effects of cortisol administration on episodic and working memory in aging veterans with PTSD. Neuropsychopharmacology. 2007 Dec;32(12):2581-91. Epub 2007 Mar 28.</citation>
    <PMID>17392739</PMID>
  </reference>
  <reference>
    <citation>Yehuda R. Post-traumatic stress disorder. N Engl J Med. 2002 Jan 10;346(2):108-14. Review.</citation>
    <PMID>11784878</PMID>
  </reference>
  <reference>
    <citation>Anisman H, Griffiths J, Matheson K, Ravindran AV, Merali Z. Posttraumatic stress symptoms and salivary cortisol levels. Am J Psychiatry. 2001 Sep;158(9):1509-11.</citation>
    <PMID>11532740</PMID>
  </reference>
  <reference>
    <citation>Delahanty DL, Raimonde AJ, Spoonster E. Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol Psychiatry. 2000 Nov 1;48(9):940-7.</citation>
    <PMID>11074232</PMID>
  </reference>
  <reference>
    <citation>Delahanty DL, Raimonde AJ, Spoonster E, Cullado M. Injury severity, prior trauma history, urinary cortisol levels, and acute PTSD in motor vehicle accident victims. J Anxiety Disord. 2003;17(2):149-64.</citation>
    <PMID>12614659</PMID>
  </reference>
  <reference>
    <citation>Resnick HS, Yehuda R, Pitman RK, Foy DW. Effect of previous trauma on acute plasma cortisol level following rape. Am J Psychiatry. 1995 Nov;152(11):1675-7.</citation>
    <PMID>7485635</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, Bryant R, Marmar C, Zohar J. Pathological responses to terrorism. Neuropsychopharmacology. 2005 Oct;30(10):1793-805. Review.</citation>
    <PMID>16012535</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, McFarlane AC, Shalev AY. Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry. 1998 Dec 15;44(12):1305-13. Review.</citation>
    <PMID>9861473</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, LeDoux J. Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron. 2007 Oct 4;56(1):19-32. Review.</citation>
    <PMID>17920012</PMID>
  </reference>
  <reference>
    <citation>Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry. 1993 Apr;50(4):295-305. Review.</citation>
    <PMID>8466391</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, Halligan SL, Bierer LM. Cortisol levels in adult offspring of Holocaust survivors: relation to PTSD symptom severity in the parent and child. Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):171-80.</citation>
    <PMID>11750777</PMID>
  </reference>
  <reference>
    <citation>Marmar CR, McCaslin SE, Metzler TJ, Best S, Weiss DS, Fagan J, Liberman A, Pole N, Otte C, Yehuda R, Mohr D, Neylan T. Predictors of posttraumatic stress in police and other first responders. Ann N Y Acad Sci. 2006 Jul;1071:1-18. Review.</citation>
    <PMID>16891557</PMID>
  </reference>
  <reference>
    <citation>Neylan TC, Brunet A, Pole N, Best SR, Metzler TJ, Yehuda R, Marmar CR. PTSD symptoms predict waking salivary cortisol levels in police officers. Psychoneuroendocrinology. 2005 May;30(4):373-81. Epub 2005 Jan 11.</citation>
    <PMID>15694117</PMID>
  </reference>
  <reference>
    <citation>Pariante CM, Nemeroff CB, Miller AH. Glucocorticoid receptors in depression. Isr J Med Sci. 1995 Dec;31(12):705-12. Review.</citation>
    <PMID>8543464</PMID>
  </reference>
  <reference>
    <citation>Sautter FJ, Bissette G, Wiley J, Manguno-Mire G, Schoenbachler B, Myers L, Johnson JE, Cerbone A, Malaspina D. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol Psychiatry. 2003 Dec 15;54(12):1382-8.</citation>
    <PMID>14675802</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, Engel SM, Brand SR, Seckl J, Marcus SM, Berkowitz GS. Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J Clin Endocrinol Metab. 2005 Jul;90(7):4115-8. Epub 2005 May 3.</citation>
    <PMID>15870120</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, Teicher MH, Seckl JR, Grossman RA, Morris A, Bierer LM. Parental posttraumatic stress disorder as a vulnerability factor for low cortisol trait in offspring of holocaust survivors. Arch Gen Psychiatry. 2007 Sep;64(9):1040-8.</citation>
    <PMID>17768269</PMID>
  </reference>
  <reference>
    <citation>Cohen H, Zohar J, Gidron Y, Matar MA, Belkind D, Loewenthal U, Kozlovsky N, Kaplan Z. Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biol Psychiatry. 2006 Jun 15;59(12):1208-18. Epub 2006 Feb 3.</citation>
    <PMID>16458266</PMID>
  </reference>
  <reference>
    <citation>Harvey BH, Brand L, Jeeva Z, Stein DJ. Cortical/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder. Physiol Behav. 2006 May 30;87(5):881-90. Epub 2006 Mar 6.</citation>
    <PMID>16546226</PMID>
  </reference>
  <reference>
    <citation>Kohda K, Harada K, Kato K, Hoshino A, Motohashi J, Yamaji T, Morinobu S, Matsuoka N, Kato N. Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model. Neuroscience. 2007 Aug 10;148(1):22-33. Epub 2007 Jul 17.</citation>
    <PMID>17644267</PMID>
  </reference>
  <reference>
    <citation>Mason JW, Giller EL, Kosten TR, Ostroff RB, Podd L. Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis. 1986 Mar;174(3):145-9.</citation>
    <PMID>3950596</PMID>
  </reference>
  <reference>
    <citation>Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry. 1996 Jul 15;40(2):79-88.</citation>
    <PMID>8793040</PMID>
  </reference>
  <reference>
    <citation>Oquendo MA, Echavarria G, Galfalvy HC, Grunebaum MF, Burke A, Barrera A, Cooper TB, Malone KM, John Mann J. Lower cortisol levels in depressed patients with comorbid post-traumatic stress disorder. Neuropsychopharmacology. 2003 Mar;28(3):591-8. Epub 2002 Aug 19.</citation>
    <PMID>12629542</PMID>
  </reference>
  <reference>
    <citation>Rohleder N, Joksimovic L, Wolf JM, Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol Psychiatry. 2004 Apr 1;55(7):745-51.</citation>
    <PMID>15039004</PMID>
  </reference>
  <reference>
    <citation>Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am. 2002 Jun;25(2):341-68, vii. Review.</citation>
    <PMID>12136504</PMID>
  </reference>
  <reference>
    <citation>Bremner JD, Southwick SM, Johnson DR, Yehuda R, Charney DS. Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am J Psychiatry. 1993 Feb;150(2):235-9.</citation>
    <PMID>8422073</PMID>
  </reference>
  <reference>
    <citation>Marazziti D, Catena Dell'osso M. The role of oxytocin in neuropsychiatric disorders. Curr Med Chem. 2008;15(7):698-704. Review.</citation>
    <PMID>18336283</PMID>
  </reference>
  <reference>
    <citation>Heinrichs M, Domes G. Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. Prog Brain Res. 2008;170:337-50. doi: 10.1016/S0079-6123(08)00428-7. Review.</citation>
    <PMID>18655894</PMID>
  </reference>
  <reference>
    <citation>Bartz JA, Hollander E. The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior. Horm Behav. 2006 Nov;50(4):518-28. Epub 2006 Aug 1. Review.</citation>
    <PMID>16884725</PMID>
  </reference>
  <reference>
    <citation>Neumann ID. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog Brain Res. 2002;139:147-62. Review.</citation>
    <PMID>12436933</PMID>
  </reference>
  <reference>
    <citation>Carter CS, Altemus M. Integrative functions of lactational hormones in social behavior and stress management. Ann N Y Acad Sci. 1997 Jan 15;807:164-74. Review.</citation>
    <PMID>9071349</PMID>
  </reference>
  <reference>
    <citation>Lightman SL, Young WS 3rd. Lactation inhibits stress-mediated secretion of corticosterone and oxytocin and hypothalamic accumulation of corticotropin-releasing factor and enkephalin messenger ribonucleic acids. Endocrinology. 1989 May;124(5):2358-64.</citation>
    <PMID>2785027</PMID>
  </reference>
  <reference>
    <citation>Neumann ID, Johnstone HA, Hatzinger M, Liebsch G, Shipston M, Russell JA, Landgraf R, Douglas AJ. Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes. J Physiol. 1998 Apr 1;508 ( Pt 1):289-300.</citation>
    <PMID>9490853</PMID>
  </reference>
  <reference>
    <citation>Stern JM, Goldman L, Levine S. Pituitary-adrenal responsiveness during lactation in rats. Neuroendocrinology. 1973;12(3):179-91.</citation>
    <PMID>4353345</PMID>
  </reference>
  <reference>
    <citation>Thoman EB, Conner RL, Levine S. Lactation suppresses adrenal corticosteroid activity and aggressiveness in rats. J Comp Physiol Psychol. 1970 Mar;70(3):364-9.</citation>
    <PMID>5461489</PMID>
  </reference>
  <reference>
    <citation>Walker CD, Lightman SL, Steele MK, Dallman MF. Suckling is a persistent stimulus to the adrenocortical system of the rat. Endocrinology. 1992 Jan;130(1):115-25.</citation>
    <PMID>1309321</PMID>
  </reference>
  <reference>
    <citation>Windle RJ, Wood S, Shanks N, Perks P, Conde GL, da Costa AP, Ingram CD, Lightman SL. Endocrine and behavioural responses to noise stress: comparison of virgin and lactating female rats during non-disrupted maternal activity. J Neuroendocrinol. 1997 Jun;9(6):407-14.</citation>
    <PMID>9229351</PMID>
  </reference>
  <reference>
    <citation>Uvnäs-Moberg K. Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology. 1998 Nov;23(8):819-35. Review.</citation>
    <PMID>9924739</PMID>
  </reference>
  <reference>
    <citation>Uvnäs-Moberg K, Ahlenius S, Hillegaart V, Alster P. High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol Biochem Behav. 1994 Sep;49(1):101-6.</citation>
    <PMID>7816858</PMID>
  </reference>
  <reference>
    <citation>Lundeberg T, Uvnäs-Moberg K, Agren G, Bruzelius G. Anti-nociceptive effects of oxytocin in rats and mice. Neurosci Lett. 1994 Mar 28;170(1):153-7.</citation>
    <PMID>8041495</PMID>
  </reference>
  <reference>
    <citation>Heinrichs M, Meinlschmidt G, Neumann I, Wagner S, Kirschbaum C, Ehlert U, Hellhammer DH. Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. J Clin Endocrinol Metab. 2001 Oct;86(10):4798-804.</citation>
    <PMID>11600543</PMID>
  </reference>
  <reference>
    <citation>Uvnäs-Moberg K. Neuroendocrinology of the mother-child interaction. Trends Endocrinol Metab. 1996 May-Jun;7(4):126-31.</citation>
    <PMID>18406738</PMID>
  </reference>
  <reference>
    <citation>Legros JJ, Chiodera P, Geenen V, Smitz S, von Frenckell R. Dose-response relationship between plasma oxytocin and cortisol and adrenocorticotropin concentrations during oxytocin infusion in normal men. J Clin Endocrinol Metab. 1984 Jan;58(1):105-9.</citation>
    <PMID>6315753</PMID>
  </reference>
  <reference>
    <citation>Legros JJ, Chiodera P, Demey-Ponsart E. Inhibitory influence of exogenous oxytocin on adrenocorticotropin secretion in normal human subjects. J Clin Endocrinol Metab. 1982 Dec;55(6):1035-9.</citation>
    <PMID>6290521</PMID>
  </reference>
  <reference>
    <citation>Chiodera P, Coiro V. Oxytocin reduces metyrapone-induced ACTH secretion in human subjects. Brain Res. 1987 Sep 8;420(1):178-81.</citation>
    <PMID>2823973</PMID>
  </reference>
  <reference>
    <citation>Suh BY, Liu JH, Rasmussen DD, Gibbs DM, Steinberg J, Yen SS. Role of oxytocin in the modulation of ACTH release in women. Neuroendocrinology. 1986;44(3):309-13.</citation>
    <PMID>3027599</PMID>
  </reference>
  <reference>
    <citation>House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988 Jul 29;241(4865):540-5.</citation>
    <PMID>3399889</PMID>
  </reference>
  <reference>
    <citation>DeVries AC, Glasper ER, Detillion CE. Social modulation of stress responses. Physiol Behav. 2003 Aug;79(3):399-407. Review.</citation>
    <PMID>12954434</PMID>
  </reference>
  <reference>
    <citation>Henry JP, Wang S. Effects of early stress on adult affiliative behavior. Psychoneuroendocrinology. 1998 Nov;23(8):863-75. Review.</citation>
    <PMID>9924741</PMID>
  </reference>
  <reference>
    <citation>Insel TR, Young LJ. The neurobiology of attachment. Nat Rev Neurosci. 2001 Feb;2(2):129-36. Review.</citation>
    <PMID>11252992</PMID>
  </reference>
  <reference>
    <citation>Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry. 2003 Dec 15;54(12):1389-98.</citation>
    <PMID>14675803</PMID>
  </reference>
  <reference>
    <citation>Winslow JT, Noble PL, Lyons CK, Sterk SM, Insel TR. Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys. Neuropsychopharmacology. 2003 May;28(5):910-8. Epub 2003 Mar 26.</citation>
    <PMID>12700704</PMID>
  </reference>
  <reference>
    <citation>Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature. 2005 Jun 2;435(7042):673-6.</citation>
    <PMID>15931222</PMID>
  </reference>
  <reference>
    <citation>Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci. 2005 Dec 7;25(49):11489-93.</citation>
    <PMID>16339042</PMID>
  </reference>
  <reference>
    <citation>Breslau N, Chilcoat HD, Kessler RC, Davis GC. Previous exposure to trauma and PTSD effects of subsequent trauma: results from the Detroit Area Survey of Trauma. Am J Psychiatry. 1999 Jun;156(6):902-7.</citation>
    <PMID>10360130</PMID>
  </reference>
  <reference>
    <citation>Keane TM, Gerardi RJ, Lyons JA, Wolfe J. The interrelationship of substance abuse and posttraumatic stress disorder. Epidemiological and clinical considerations. Recent Dev Alcohol. 1988;6:27-48. Review.</citation>
    <PMID>3283857</PMID>
  </reference>
  <reference>
    <citation>Schumm JA, Briggs-Phillips M, Hobfoll SE. Cumulative interpersonal traumas and social support as risk and resiliency factors in predicting PTSD and depression among inner-city women. J Trauma Stress. 2006 Dec;19(6):825-36.</citation>
    <PMID>17195981</PMID>
  </reference>
  <reference>
    <citation>Yehuda R. Biological factors associated with susceptibility to posttraumatic stress disorder. Can J Psychiatry. 1999 Feb;44(1):34-9. Review.</citation>
    <PMID>10076739</PMID>
  </reference>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2009</study_first_submitted>
  <study_first_submitted_qc>December 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 25, 2009</study_first_posted>
  <last_update_submitted>February 7, 2010</last_update_submitted>
  <last_update_submitted_qc>February 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof. Joseph Zohar</name_title>
    <organization>Sheba Medical Center</organization>
  </responsible_party>
  <keyword>post traumatic stress disorder</keyword>
  <keyword>prevention</keyword>
  <keyword>oxytocin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

